Chemotargets to open EUR 15m funding round to start the development of drugs focused on oncology
Chemotargets abriría una ronda de financiación de EUR 15m para iniciar el desarrollo de fármacos enfocados en oncología
Intel ID : 296860
|
Intel ID | 296860 | ||
Value | EUR 15,00m | ||
Native Currency | Euro (EUR) | ||
Financial Data - Chemotargets
(31 Dec 2021) |
Revenue: EUR 1,03m Net Debt: EUR 2,58m People: 22 |
||
Date |
![]() |
||
Country | ![]() |
||
Geography | ![]() |
||
Subsector (Old TTR Sectors) |
|
||
Type |
![]() |
||
Intel Grade |
![]() |
||
Source |
![]() |
||
Tags | ![]() |
Target
Name |
|
||
Subsector (Old TTR Sectors) |
|
||
Primary Sector (TTRSC) |
30.01.99 Other Biotechnology & Pharmaceuticals 30 Healthcare / 30.01 Biotechnology & Pharmaceuticals |
||
Secondary Sectors (TTRSC) |
15.06.01 Colleges & Universities 15 Consumer Products & Services / 15.06 Education & Training Services |
||
Country |
![]() |
||
Website |
![]() |
||
Description |
![]() |
Legend:
Verified: Confirmed as a party to an active or possible transaction.
Potential: Unconfirmed as a party to an active or possible transaction.
Retained: Confirmed as “Retained” with a general or specific mandate.
Prospect: Advisory “Prospect” in discussions with or pitching services to possible client.
Transactional data is continuously updated by the research team and therefore is subject to change.